Needham analyst Mike Matson upgrades NeoGenomics (NASDAQ:NEO) from Hold to Buy and announces $15 price target.
KBR Secures Contract From A Leading Midstream Company For A World-scale Olefins Production Facility To Be Built On The U.S. Gulf Coast
KBR (NYSE:KBR) announced today that it has secured a contract from a leading midstream company for a world-scale olefins production facility to be built on the U.S. Gulf Coast.
Under the terms of the contract, KBR will
